When “Close Enough” Isn’t Good Enough: The Risk to Patients Therapeutic Drug Monitoring (TDM) exists because small deviations in drug concentrations can have significant consequences. For drugs with narrow therapeutic windows, such as digoxin, lithium, or ...
As the opioid epidemic has evolved, a new threat has emerged in the form of Xylazine. Learn how UTAK helped one healthcare network fight back....
To help your lab prioritize its compliance strategy, use this checklist to determine where your lab stands in relation to the FDA’s final rule....
The FDA's Final Rule on laboratory developed tests (LDTs) marks a dramatic shift in how testing labs will operate. Here's what you need to know....